Everglades Biopharma is a Houston-based biopharmaceutical company developing ligand-based therapies for diverse diseases. Currently, the Company focuses on anti-angiogenic therapies against novel disease-specific ligands for vascular diseases, such as wet AMD, diabetic macular edema and cancer...
The Company has used this innovative ligandomics technology to successfully identify a dozen disease-specific angiogenic ligands as therapeutic targets. Everglades Biopharma focuses on the develop therapeutic antibodies for anti-angiogenic therapy of wet AMD and diabetic retinopathy.